Flow cytometry is a valuable tool used to gain information pertinent to the immunotoxicity of pharmaceuticals.
Toronto, Canada (PRWEB) June 14, 2013
Flow cytometry is a valuable tool used to gain information pertinent to the immunotoxicity of pharmaceuticals. These assays can be integrated into preclinical toxicology studies and used on all standard toxicology species including mice, rats, dogs, nonhuman primates, and pigs.
Current Good Laboratory Practices (GLP) requires flow cytometry assays to be validated. In other words, these assays must meet stringent benchmarks in assay precision, reproducibility, and stability.
Currently, there are ongoing discussions and widely varying practices in the design of flow cytometry validation studies. This is due to a combination of challenges such as heterogeneous cell populations, lack of reference material for accuracy evaluation, and instrumentation complexity.
This webinar event, featuring experts from MPI Research, will explore optimization and validation strategies for flow cytometry assays.
Speakers will share their insights on:
- Considerations for the inclusion of flow cytometry assays in toxicology studies
- Current best practices for developing and validating a flow cytometry assay for use in GLP studies
- Flow cytometry assays used by MPI Research for immunotoxicology evaluation and drug discovery applications
To learn more about the event, visit: http://www.xtalks.com/FlowCytometry.ashx.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.
Karen Lim (416) 977-6555 ext 227